Correlation Between Senti Biosciences and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Senti Biosciences and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Lixte Biotechnology.
Diversification Opportunities for Senti Biosciences and Lixte Biotechnology
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Senti and Lixte is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Senti Biosciences and Lixte Biotechnology
Given the investment horizon of 90 days Senti Biosciences is expected to generate 1.5 times more return on investment than Lixte Biotechnology. However, Senti Biosciences is 1.5 times more volatile than Lixte Biotechnology Holdings. It trades about 0.15 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.16 per unit of risk. If you would invest 381.00 in Senti Biosciences on November 2, 2024 and sell it today you would earn a total of 61.00 from holding Senti Biosciences or generate 16.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Senti Biosciences |
| Lixte Biotechnology |
Senti Biosciences and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Lixte Biotechnology
The main advantage of trading using opposite Senti Biosciences and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |